Mayo Clinic Laboratories and Lucence are expanding access to advanced cancer testing worldwide with LiquidHALLMARK®, a next-generation liquid biopsy that provides actionable genomic insights. This collaboration empowers physicians to...
5 Steps to Improve Communication in Laboratory Outreach - Insights
Communication is a critical component of success. Laboratory outreach leaders can foster truly effective communication with five simple steps.
MCL - Chain of Custody Request - MC1944
MCL - Chain of Custody Request
CPT codes and LOINC update: November 2020 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of November
The diagnosis of Myeloproliferative Neoplasm (MPN) must include an integrated approach and combine the clinical findings with laboratory results. In our latest “Hot Topic,” Rong He, M.D., discusses the subclassification of MPNs and the use...
Mayo Clinic Labs @Work: Kimberly Knight - Insights
As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their...
Mayo Clinic Labs @Work: Callie Bishop - Insights
As a director of operations for Mayo Clinic Laboratories, Callie Bishop helps meet the needs of Mayo Clinic Laboratories clients both virtually and onsite in the field.
MCL @Work: Wendy Sempf - Insights
Wendy is a clinical laboratory technologist who works in the Hematopathology Morphology Laboratory at Mayo Clinic Laboratories. Although she’s worked with Mayo Clinic since 1989, her greatest passion is serving others throughout the...
MCL @Work: Rachel Freeman - Insights
Rachel is a referral specialist serving as the important link between Mayo Clinic Laboratories and our clients. With an eye on quality assurance, she helps patients and clinicians get answers faster.
Hereditary movement disorders - Insights
Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.